Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival : Table 2

Table 2: Comparison of perioperative variables between 34 patients treated with neoadjuvant chemotherapy prior to cytoreductive surgery and HIPEC and 24 patients that did not receive preoperative chemotherapy before cytoreductive surgery and HIPEC.


Clinical characteristic	Patients with PMCA from appendix cancer
Clinical characteristic	Neoadjuvant chemotherapy	No neoadjuvant chemotherapy	P value

Number of patients	34	24
Peritoneal cancer index (mean)	19	28	0.0003
Number of peritonectomies	0.0032
Mean	2.3	3.7
Range	0–5	1–5
Number of visceral resections	<0.001
Mean	2.7	4.4
Range	1–5	2–7
Completeness of cytoreduction	0.78
CCR 0/CCR 1	22	12
CCR 2	7	5
CCR 3	5	5
Complications	0.16
None or grade1/2	8	10
Grade 3 or 4	26	14